PACB

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Peers: ILMN GH TXG CRSP QGEN TWST CDNA FLGT ONC FATE

| Held by: ARKK ARKG VTI IWM VXF IWN IBB VTWO SCHA VHT

Index	RUT	P/E	-	EPS (ttm)	-2.27	Insider Own	11.96%	Shs Outstand	300.35M	Perf Week	-7.87%
Market Cap	351.43M	Forward P/E	-	EPS next Y	-0.51	Insider Trans	-0.09%	Shs Float	264.44M	Perf Month	-8.59%
Enterprise Value	735.61M	PEG	-	EPS next Q	-0.15	Inst Own	55.96%	Short Float	14.03%	Perf Quarter	-0.85%
Income	-525.16M	P/S	2.25	EPS this Y	-50.51%	Inst Trans	-18.75%	Short Ratio	4.70	Perf Half Y	-2.50%
Sales	156.11M	P/B	5.72	EPS next Y	69.72%	ROA	-44.98%	Short Interest	37.11M	Perf YTD	-36.07%
Book/sh	0.20	P/C	1.12	EPS next 5Y	28.08%	ROE	-189.52%	52W High	2.72 -56.99%	Perf Year	-32.76%
Cash/sh	1.05	P/FCF	-	EPS past 3/5Y	-21.38% -23.55%	ROIC	-69.10%	52W Low	0.85 37.47%	Perf 3Y	-80.03%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	5.67% 11.12%	Gross Margin	-215.73%	Volatility	6.38% 6.15%	Perf 5Y	-81.92%
Dividend TTM	-	EV/Sales	4.71	EPS Y/Y TTM	-19.34%	Oper. Margin	-364.72%	ATR (14)	0.09	Perf 10Y	-75.11%
Dividend Ex-Date	-	Quick Ratio	6.02	Sales Y/Y TTM	-17.35%	Profit Margin	-336.40%	RSI (14)	40.04	Recom	2.31
Dividend Gr. 3/5Y	- -	Current Ratio	6.92	EPS Q/Q	78.04%	SMA20	-9.02%	Beta	2.11	Target Price	2.00
Payout	-	Debt/Eq	11.37	Sales Q/Q	10.42%	SMA50	-15.08%	Rel Volume	1.20	Prev Close	1.26
Employees	575	LT Debt/Eq	11.36	Earnings	Aug 07 AMC	SMA200	-18.21%	Avg Volume	7.90M	Price	1.17
IPO	Oct 27, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.70% 8.61%	Trades		Volume	9,465,276	Change	-7.14%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31
Jan-06-22	Resumed	Piper Sandler	Neutral	$20
Oct-15-21	Resumed	Cowen	Market Perform	$30

Show Previous Ratings

Sep-12-25 06:15PM	Why Pacific Biosciences of California (PACB) Dipped More Than Broader Market Today (Zacks) -7.14%
Sep-05-25 12:30PM	PACB Partners With EpiCypher to Advance Epigenomics Using Fiber-Seq (Zacks)
Sep-03-25 09:05AM	PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow (GlobeNewswire)
Aug-22-25 02:25PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +9.52%
Aug-19-25 01:51PM	Cathie Woods ARK Innovation Sees Outflows, But Buys More Deere Stock Anyway (Barrons.com)
01:34AM	Loading…
Aug-14-25 01:34AM	The Top 5 Analyst Questions From PacBio's Q2 Earnings Call (StockStory)
Aug-13-25 03:01PM	PacBio (PACB) Shares Skyrocket, What You Need To Know (StockStory) +5.79%
Aug-11-25 09:38AM	PACB Q2 Deep Dive: International Demand, Consumables Growth, and Clinical Adoption Drive Results (StockStory) -6.67%
Aug-08-25 12:21PM	PacBio (PACB) Stock Trades Up, Here Is Why (StockStory) +7.14%
12:07PM	PacBio Stock Up on Q2 Earnings & Revenue Beat Estimates, Margin Rises (Zacks)
Aug-07-25 07:30PM	Pacific Biosciences (PACB) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) -8.70%
07:00PM	Pacific Biosciences of California (PACB) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
05:58PM	Pacific Biosciences: Q2 Earnings Snapshot (Associated Press Finance)
05:07PM	PacBio (NASDAQ:PACB) Delivers Strong Q2 Numbers, Stock Soars (StockStory)
04:05PM	PacBio Announces Second Quarter 2025 Financial Results (GlobeNewswire)
05:50PM	Loading…
Aug-06-25 05:50PM	Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
09:00AM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-05-25 11:18PM	PacBio (PACB) Q2 Earnings Report Preview: What To Look For (StockStory)
Aug-04-25 09:15AM	Stay Ahead of the Game With Pacific Biosciences (PACB) Q2 Earnings: Wall Street's Insights on Key Metrics (Zacks)
09:05AM	Nature Methods Paper Leverages PacBio Sequencing Technology to Develop the Platinum Pedigree Benchmark, a New Standard for Accurate Characterization of Variation in the Human Genome that Improves Training for AI Models (GlobeNewswire)
Jul-31-25 12:03AM	3 Reasons to Avoid PACB and 1 Stock to Buy Instead (StockStory) -7.38%
Jul-29-25 06:15PM	Pacific Biosciences of California (PACB) Suffers a Larger Drop Than the General Market: Key Insights (Zacks) -6.10%
03:30PM	PacBio, 10x Genomics, QuidelOrtho, STAAR Surgical, and Clover Health Stocks Trade Down, What You Need To Know (StockStory)
09:35AM	Pacific Biosciences (PACB) Jumps 6.5% Ahead of Earnings (Insider Monkey)
08:52AM	Athena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing (PR Newswire)
Jul-24-25 09:05AM	PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications (GlobeNewswire) -8.88%
Jul-23-25 01:11PM	Why PacBio (PACB) Stock Is Up Today (StockStory)
09:05AM	PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio (GlobeNewswire)
Jul-22-25 04:05PM	QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels (Business Wire) +11.72%
Jul-21-25 04:05PM	PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025 (GlobeNewswire) +5.84%
06:15PM	Loading…
Jul-17-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks) -6.71%
Jul-10-25 06:15PM	Pacific Biosciences of California (PACB) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
Jul-09-25 11:57AM	Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
Jul-08-25 12:00PM	Pacific Biosciences (PACB) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Jul-03-25 09:08AM	Pacific Biosciences Targets Profitability by 2027 With Record Consumables Revenue (Insider Monkey) +7.38%
Jun-30-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks)
08:50AM	The 5 Most Interesting Analyst Questions From PacBio's Q1 Earnings Call (StockStory)
Jun-13-25 11:30AM	Why Is Steris (STE) Down 1.8% Since Last Earnings Report? (Zacks)
Jun-12-25 06:15PM	Pacific Biosciences of California (PACB) Outperforms Broader Market: What You Need to Know (Zacks)
Jun-10-25 06:41AM	PACB Q1 Earnings Call: Cost Reductions and Clinical Adoption Offset Market Headwinds (StockStory)
Jun-05-25 12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
Jun-04-25 11:31PM	Q1 Earnings Roundup: PacBio (NASDAQ:PACB) And The Rest Of The Life Sciences Tools & Services Segment (StockStory)
Jun-02-25 10:00AM	Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date (PR Newswire)
May-29-25 12:00PM	All You Need to Know About Pacific Biosciences (PACB) Rating Upgrade to Buy (Zacks) -5.45%
May-28-25 09:00AM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) +20.85%
May-23-25 10:46AM	PacBio Stock Slips Despite New China Distribution Deal With Haorui (Zacks)
May-22-25 09:05AM	PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene (GlobeNewswire)
May-12-25 01:04PM	PACB Stock May Rise Following the Deal With Chulalongkorn University (Zacks)
10:56AM	PacBio Board Independent Investigation Concludes Allegations Unsubstantiated (GlobeNewswire)
May-09-25 12:00PM	PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates (Zacks) -6.67%
May-08-25 09:00PM	Pacific Biosciences (PACB) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks) +6.19%
05:30PM	Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:29PM	Pacific Biosciences: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	PacBio Announces First Quarter 2025 Financial Results (GlobeNewswire)
May-07-25 12:38PM	Pacific Biosciences of California Q1 2025 Earnings Preview (Seeking Alpha)
11:08AM	Earnings To Watch: Pacific Biosciences of California Inc (PACB) Reports Q1 2025 Result (GuruFocus.com)
May-05-25 09:05AM	First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand (GlobeNewswire)
Apr-29-25 06:15PM	Pacific Biosciences of California (PACB) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Apr-28-25 09:05AM	PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry (GlobeNewswire)
09:01AM	1 Volatile Stock to Target This Week and 2 to Keep Off Your Radar (StockStory)
Apr-23-25 06:15PM	Pacific Biosciences of California (PACB) Flat As Market Gains: What You Should Know (Zacks)
Apr-22-25 09:05AM	Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa (GlobeNewswire)
Apr-09-25 02:38PM	PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know (StockStory) +20.83%
09:05AM	PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million (GlobeNewswire)
Apr-04-25 07:45PM	PacBio Grants Equity Incentive Award to New Employee (GlobeNewswire) +7.32%
Mar-27-25 09:05AM	Jim Gibson to join PacBio as Chief Financial Officer (GlobeNewswire)
Mar-20-25 06:15PM	Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors (Zacks)
01:05PM	Here's Why You Should Retain PacBio Stock in Your Portfolio Now (Zacks)
Mar-18-25 06:15PM	Is Pacific Biosciences of California, Inc. (PACB) the Most Volatile Stock Under $3 For Day Trading? (Insider Monkey)
05:08AM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
Mar-17-25 09:05AM	Scientists Solve One of Genomics' Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes (GlobeNewswire)
05:09AM	Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks (StockStory)
Mar-14-25 06:15PM	Pacific Biosciences of California (PACB) Increases Yet Falls Behind Market: What Investors Need to Know (Zacks)
Mar-11-25 09:01AM	1 Healthcare Stock to Target This Week and 2 to Turn Down (StockStory) -5.76%
Feb-19-25 04:05PM	PacBio to Participate in TD Cowen's 45th Annual Health Care Conference (GlobeNewswire) -5.35% -7.34%
Feb-15-25 11:02AM	PacBio should return to growth over time, says Canaccord (TipRanks)
Feb-14-25 11:09PM	PacBio Grants Equity Incentive Award to New Employee (GlobeNewswire) +25.00%
02:21AM	Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Call Highlights: Navigating ... (GuruFocus.com)
Feb-13-25 06:00PM	Compared to Estimates, Pacific Biosciences (PACB) Q4 Earnings: A Look at Key Metrics (Zacks) +8.82%
05:20PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:13PM	PacBio (NASDAQ:PACB) Misses Q4 Sales Targets (StockStory)
04:28PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial Results (GlobeNewswire)
Feb-12-25 08:03AM	PacBio (PACB) Q4 Earnings Report Preview: What To Look For (StockStory)
07:42AM	Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Feb-04-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: Here's Why (Zacks) +13.89%
Feb-03-25 09:05AM	PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service (GlobeNewswire) -5.19%
Jan-30-25 04:05PM	PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025 (GlobeNewswire)
09:05AM	PacBio Announces Appointment of Chris Smith to Board of Directors (GlobeNewswire)
Jan-29-25 09:05AM	PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics (GlobeNewswire)
Jan-27-25 06:15PM	Pacific Biosciences of California (PACB) Stock Moves -1.18%: What You Should Know (Zacks)
Jan-24-25 09:16AM	PacBio announces GIFS at USask as first Revio PacBio CSP in Canada (TipRanks)
Jan-23-25 09:05AM	PacBio Names Global Institute for Food Security as Canada's First Revio Certified Service Provider (GlobeNewswire) -8.84%
Jan-14-25 09:05AM	PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics (GlobeNewswire) -7.96%
09:00AM	PacBio Announces Preliminary Fourth Quarter and Full Year Revenue (GlobeNewswire)
Jan-10-25 06:05AM	PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing (GlobeNewswire)
Jan-08-25 09:05AM	PacBio Announces Shipment of Vega Systems to Berry Genomics to Support its Clinical Assay Development for Asian Markets (GlobeNewswire)
Jan-07-25 06:15PM	Why the Market Dipped But Pacific Biosciences of California (PACB) Gained Today (Zacks)
11:55AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jan-02-25 04:05PM	PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +10.56%

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Van Oene Mark	See Remarks	Aug 18 '25	Sale	1.31	26,836	35,182	1,920,035	Aug 20 04:06 PM
MARK VAN OENE	Officer	Aug 18 '25	Proposed Sale	1.31	26,836	35,174		Aug 18 04:07 PM
Farmer Michele	See Remarks	May 19 '25	Sale	1.00	5,195	5,200	269,259	May 21 04:09 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '25	Sale	1.41	12,497	17,583	2,225,357	Mar 05 04:37 PM
Van Oene Mark	See Remarks	Mar 03 '25	Sale	1.41	6,486	9,126	1,497,695	Mar 05 04:37 PM
Farmer Michele	See Remarks	Mar 03 '25	Sale	1.41	2,973	4,183	184,619	Mar 05 04:36 PM
MARK VAN OENE	Officer	Mar 03 '25	Proposed Sale	1.41	6,486	9,123		Mar 03 05:11 PM
CHRISTIAN HENRY	Officer	Mar 03 '25	Proposed Sale	1.41	12,497	17,578		Mar 03 05:06 PM
Farmer Michele	See Remarks	Feb 18 '25	Sale	1.88	24,349	45,727	187,592	Feb 19 05:00 PM
Van Oene Mark	See Remarks	Feb 18 '25	Sale	1.88	100,773	189,252	1,496,681	Feb 19 04:59 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '25	Sale	1.88	259,909	488,109	2,237,854	Feb 19 04:58 PM
CHRISTIAN HENRY	Officer	Feb 18 '25	Proposed Sale	1.88	259,909	488,109		Feb 18 05:59 PM
MARK VAN OENE	Officer	Feb 18 '25	Proposed Sale	1.88	100,773	189,252		Feb 18 05:56 PM
Van Oene Mark	See Remarks	Jan 10 '25	Sale	2.03	34,405	69,980	1,597,454	Jan 10 04:54 PM
MARK VAN OENE	Officer	Jan 10 '25	Proposed Sale	2.03	34,405	69,980		Jan 10 04:23 PM
Kim Susan G.	See Remarks	Sep 30 '24	Sale	1.72	19,782	34,065	695,654	Oct 02 04:13 PM
SUSAN KIM	Officer	Sep 30 '24	Proposed Sale	1.72	19,782	34,061		Sep 30 04:03 PM
HENRY CHRISTIAN O	See Remarks	Sep 16 '24	Sale	1.75	98,907	172,692	2,497,763	Sep 17 04:11 PM
CHRISTIAN HENRY	Officer	Sep 16 '24	Proposed Sale	1.75	98,907	172,741		Sep 16 05:40 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Pacific Biosciences of California Inc

Upgrade your FINVIZ experience